| Business Summary | | Somanetics
Corporation
develops,
manufactures
and
markets
the
INVOS
Cerebral
Oximeter,
a
non-invasive
patient
monitoring
system
that
continuously
measures
changes
in
the
blood
oxygen
level
in
the
brain.
The
Company
developed
the
Cerebral
Oximeter
to
meet
the
need
for
information
about
oxygen
in
the
brain,
the
organ
least
tolerant
of
oxygen
deprivation.
The
Company
is
also
developing
the
CorRestore
patch,
a
new
cardiac
implant
designed
by
CorRestore
LLC,
for
use
in
heart
surgeries
called
surgical
anterior
ventricular
restoration. | More
from
Market Guide: Expanded
Business Description |
| Financial Summary | | Somanetics
Corp.
develops,
manufactures
and
markets
the
INVOS
Cerebral
Oximeter,
the
only
FDA-cleared,
non-invasive
patient
monitoring
system
that
measures
changes
in
the
blood
oxygen
levels
in
the
adult
brain.
For
the
six
months
ended
5/31/01
revenues
rose
9%
to
$2.7
million.
Net
loss
fell
14%
to
$1.6
million.
Results
reflect
increased
sales
of
the
Cerebral
Oximeter
and
SomaSensors.
Lower
loss
reflects
improved
margins
due
to
higher
selling
prices. | More
from
Market Guide: Significant
Developments |
| | | | FY2000 Pay | |
| H. Raymond Wallace, 65 Chairman | -- | Bruce Barrett, 41 Pres,
CEO | $246K | William Iacona, 30 VP-Fin.,
Treasurer, Controller | -- | Pamela Winters, 42 Vice
Presiden - Operations | 89K | Ronald Widman, 50 VP
- Medical Affairs | 93K | Dollar amounts are as of 30-Nov-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.. |
| More
from
Market Guide on Officers & Directors: Expanded
List, Bios,
Compensation,
Options
|
|